FiercePharma19h
JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says
These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
Marketing Dive5h
Bayer Achieves 32% Increase in Media Efficiency With Incremental and Skai
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
Acute Coronary Syndrome Market to Showcase a Significant Growth at a CAGR of 7.7% by 2034 | DelveInsight
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...
DelveInsight Business Research, LLP: Acute Coronary Syndrome Market to Showcase a Significant Growth at a CAGR of 7.7% by 2034 | DelveInsight
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...
Campaign US5h
Exclusive: How Bayer cracked the retail media code
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
Indiatimes22h
Bayer Cropsc. - Bayer Cropscience Share Price
Bayer Cropscience Ltd. key Products/Revenue Segments include Insecticides, Pesticides, Herbicides, Weedicides & Fungicides, Other Operating Revenue, Scrap and Royalty Income for the year ending 31-Mar ...